Perspective Therapeutics Inc
(CATX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CATX | AKBA | TARA | ||
| Company | Perspective Therapeutics Inc | Akebia Therapeutics | Artara Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | ||
| Open | 4.72 | 1.3600 | 6.66 | ||
| High | 4.78 | 1.4000 | 6.89 | ||
| Low | 4.45 | 1.3301 | 6.60 | ||
| Latest | 4.71 | 1.3900 | 6.65 | ||
| Change | +0.08 | +0.0100 | +0.15 | ||
| % Change | +1.73% | +0.72% | +2.31% | ||
| Volume | 1,724,100 | 3,420,900 | 615,200 | ||
| 20-Day Average Volume | 7,211,280 | 3,089,595 | 1,133,070 | ||
| Previous Close | 4.63 | 1.3800 | 6.50 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.31 | 1.4035 | 6.16 | ||
| 20-Day Raw Stochastic | 62.92% | 37.50% | 71.53% | ||
| 20-Day Relative Strength | 65.51 | 41.89 | 57.43 | ||
| Weighted Alpha | +33.63 | -47.89 | +34.02 | ||
| Today's Opinion | 40% Buy | 100% Sell | 100% Buy | ||
| Previous Opinion | 40% Buy | 100% Sell | 100% Buy | ||
| Last Month's Opinion | 32% Sell | 100% Sell | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +24.27% since 01/30/26 | -1.42% since 01/30/26 | -6.07% since 01/30/26 | ||
| Low | 4.00 on 02/02/26 | 1.3301 on 02/06/26 | 6.41 on 02/04/26 | ||
| High | 5.89 on 02/02/26 | 1.4400 on 02/03/26 | 7.29 on 02/02/26 | ||
| 1-Month | |||||
| %Chg | +67.62% since 01/06/26 | -5.44% since 01/06/26 | +29.88% since 01/06/26 | ||
| Low | 2.25 on 01/20/26 | 1.3000 on 01/20/26 | 4.72 on 01/16/26 | ||
| High | 6.16 on 01/29/26 | 1.5650 on 01/07/26 | 7.42 on 01/28/26 | ||
| 3-Month | |||||
| %Chg | +111.21% since 11/06/25 | -30.85% since 11/06/25 | +55.01% since 11/06/25 | ||
| Low | 1.96 on 11/21/25 | 1.3000 on 01/20/26 | 4.11 on 11/07/25 | ||
| High | 6.16 on 01/29/26 | 2.0700 on 11/07/25 | 7.82 on 11/24/25 | ||
| 6-Month | |||||
| %Chg | +23.30% since 08/06/25 | -63.28% since 08/06/25 | +113.83% since 08/06/25 | ||
| Low | 1.96 on 11/21/25 | 1.3000 on 01/20/26 | 2.97 on 08/20/25 | ||
| High | 6.16 on 01/29/26 | 3.4400 on 08/11/25 | 7.82 on 11/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 344,185 | 366,205 | 335,602 | ||
| Shares Outstanding, K | 74,338 | 265,366 | 51,631 | ||
| Annual Sales | 1,450,000 | 160,180,000 | 0 | ||
| Annual Net Income | -79,280,000 | -69,410,000 | -44,600,000 | ||
| Last Quarter Sales | 210,000 | 58,770,000 | 0 | ||
| Last Quarter Net Income | -25,970,000 | 540,000 | -13,260,000 | ||
| 60-Month Beta | 1.75 | 0.38 | 1.38 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 11/10/25 | 0.00 on 11/10/25 | -0.31 on 11/10/25 | ||
| Latest Earnings Date | 03/25/26 | 03/12/26 | 03/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||